Inventor

GERETTI ELENA

US3 patents

Patents

3 patents

US9226966B2Jan 5, 2016

Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents

MERRIMACK PHARMACEUTICALS INC2 citations54

US9913901B2Mar 13, 2018

Combination therapy for treating HER2-positive cancers

MERRIMACK PHARMACEUTICALS INC0 citations45

US9610249B2Apr 4, 2017

Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents

MERRIMACK PHARMACEUTICALS INC0 citations44